Magnetic Resonance Imaging
Volume 28, Issue 4 , Pages 477-486 , May 2010

Unfolding the long-term pathophysiological processes following an acute inflammatory demyelinating lesion of multiple sclerosis

  • Wafaa Zaaraoui

      Affiliations

    • CRMBM UMR CNRS 6612–Medical School of Marseille, 13005 Marseille, France
    • Corresponding Author InformationCorresponding author. Tel.: +33 4 91 38 84 63; fax: +33 4 91 38 84 61.
    • ,
  • Audrey Rico

      Affiliations

    • CRMBM UMR CNRS 6612–Medical School of Marseille, 13005 Marseille, France
    • Department of Neurology, Timone University Hospital, 13005 Marseille, France
    • ,
  • Bertrand Audoin

      Affiliations

    • CRMBM UMR CNRS 6612–Medical School of Marseille, 13005 Marseille, France
    • Department of Neurology, Timone University Hospital, 13005 Marseille, France
    • ,
  • Françoise Reuter

      Affiliations

    • CRMBM UMR CNRS 6612–Medical School of Marseille, 13005 Marseille, France
    • ,
  • Irina Malikova

      Affiliations

    • CRMBM UMR CNRS 6612–Medical School of Marseille, 13005 Marseille, France
    • Department of Neurology, Timone University Hospital, 13005 Marseille, France
    • ,
  • Elisabeth Soulier

      Affiliations

    • CRMBM UMR CNRS 6612–Medical School of Marseille, 13005 Marseille, France
    • ,
  • Patrick Viout

      Affiliations

    • CRMBM UMR CNRS 6612–Medical School of Marseille, 13005 Marseille, France
    • ,
  • Yann Le Fur

      Affiliations

    • CRMBM UMR CNRS 6612–Medical School of Marseille, 13005 Marseille, France
    • ,
  • Sylviane Confort-Gouny

      Affiliations

    • CRMBM UMR CNRS 6612–Medical School of Marseille, 13005 Marseille, France
    • ,
  • Patrick J. Cozzone

      Affiliations

    • CRMBM UMR CNRS 6612–Medical School of Marseille, 13005 Marseille, France
    • ,
  • Jean Pelletier

      Affiliations

    • CRMBM UMR CNRS 6612–Medical School of Marseille, 13005 Marseille, France
    • Department of Neurology, Timone University Hospital, 13005 Marseille, France
    • ,
  • Jean-Philippe Ranjeva

      Affiliations

    • CRMBM UMR CNRS 6612–Medical School of Marseille, 13005 Marseille, France

Received 30 April 2009 ,Revised 14 July 2009 ,Accepted 6 December 2009.

References 

  1. Miller DH. Biomarkers and surrogate outcomes in neurodegenerative disease: lessons from multiple sclerosis. NeuroRx. 2004;1(2):284–294
  2. Zivadinov R, et al. The place of conventional MRI and newly emerging MRI techniques in monitoring different aspects of treatment outcome. J Neurol. 2008;255(Suppl 1):61–74
  3. Mezzapesa DM, et al. Functional cortical changes of the sensorimotor network are associated with clinical recovery in multiple sclerosis. Hum Brain Mapp. 2008;29(5):562–573
  4. Ernst T, et al. Physiologic MRI of a tumefactive multiple sclerosis lesion. Neurology. 1998;51(5):1486–1488
  5. Law M, Meltzer DE, Cha S. Spectroscopic magnetic resonance imaging of a tumefactive demyelinating lesion. Neuroradiology. 2002;44(12):986–989
  6. Silver NC, et al. Proton magnetic resonance spectroscopy in a pathologically confirmed acute demyelinating lesion. J Neurol. 1997;244(3):204–207
  7. Tsui EY, et al. Tumefactive demyelinating lesions by combined perfusion-weighted and diffusion weighted imaging. Comput Med Imaging Graph. 2002;26(5):343–346
  8. Brex PA, et al. A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med. 2002;346(3):158–164
  9. Davie CA, et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain. 1994;117(Pt 1):49–58
  10. Filippi M, et al. Magnetization transfer changes in the normal appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol. 1998;43(6):809–814
  11. Rovira A, et al. Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR images. AJNR Am J Neuroradiol. 1999;20(10):1939–1945
  12. Silver NC, et al. A modified protocol to improve the detection of enhancing brain and spinal cord lesions in multiple sclerosis. J Neurol. 2001;248(3):215–224
  13. McDonald WI, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121–127
  14. Frahm J, et al. Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med. 1989;11(1):47–63
  15. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann N Y Acad Sci. 1987;508:333–348
  16. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson. 1997;129(1):35–43
  17. Audoin B, et al. Onset and underpinnings of white matter atrophy at the very early stage of multiple sclerosis — a two-year longitudinal MRI/MRSI study of corpus callosum. Mult Scler. 2007;13:41–51
  18. Confort-Gouny S, et al. A multiparametric data analysis showing the potential of localized proton MR spectroscopy in the brain in the metabolic characterization of neurological diseases. J Neurol Sci. 1993;118:123–133
  19. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 1983;33(11):1444–1452
  20. Barker PB, Lin DDM. In vivo proton MR spectroscopy of the human brain. Prog Nucl Magn Reson Spectrosc. 2006;(49):99–128
  21. Waubant E. Biomarkers indicative of blood-brain barrier disruption in multiple sclerosis. Dis Markers. 2006;22(4):235–244
  22. Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience. 1991;45(1):37–45
  23. Ross B, Bluml S. Magnetic resonance spectroscopy of the human brain. Anat Rec. 2001;265(2):54–84
  24. Cucurella MG, et al. Serial proton spectroscopy, magnetization transfer ratio and T 2 relaxation in pseudotumoral demyelinating lesions. NMR Biomed. 2002;15(4):284–292
  25. De Stefano N, et al. Chemical pathology of acute demyelinating lesions and its correlation with disability. Ann Neurol. 1995;38(6):901–909
  26. Reddy H, et al. Relating axonal injury to functional recovery in MS. Neurology. 2000;54(1):236–239
  27. Gass A, Niendorf T, Hirsch JG. Acute and chronic changes of the apparent diffusion coefficient in neurological disorders — biophysical mechanisms and possible underlying histopathology. J Neurol Sci. 2001;186(Suppl 1):S15–S23
  28. McGowan JC, et al. Magnetisation transfer imaging: theory and application to multiple sclerosis. J Neurol Neurosurg Psychiatry. 1998;64(Suppl 1):S66–S69
  29. Rocca MA, et al. Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes. Lancet Neurol. 2005;4(10):618–626
  30. Correale J, Villa A. The neuroprotective role of inflammation in nervous system injuries. J Neurol. 2004;251(11):1304–1316
  31. Narayana PA. Magnetic resonance spectroscopy in the monitoring of multiple sclerosis. J Neuroimaging. 2005;15(4 Suppl):46S–57S
  32. Schmierer K, et al. Magnetization transfer ratio and myelin in postmortem multiple sclerosis brain. Ann Neurol. 2004;56(3):407–415
  33. Trebst C, et al. CCR5 expression on macrophages/microglia is associated with early remyelination in multiple sclerosis lesions. Mult Scler. 2008;14(6):728–733
  34. Fitch MT, Silver J. CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure. Exp Neurol. 2008;209(2):294–301
  35. Raivich G, Banati R. Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease. Brain Res Brain Res Rev. 2004;46(3):261–281
  36. Skaper SD. The brain as a target for inflammatory processes and neuroprotective strategies. Ann N Y Acad Sci. 2007;1122:23–34
  37. Loubinoux I, et al. Correlation between cerebral reorganization and motor recovery after subcortical infarcts. Neuroimage. 2003;20(4):2166–2180
  38. Mark VW, et al. Constraint-induced movement therapy can improve hemiparetic progressive multiple sclerosis. Preliminary findings. Mult Scler. 2008;14(7):992–994
  39. Widera D, et al. Neural stem cells, inflammation and NF-kappaB: basic principle of maintenance and repair or origin of brain tumours?. J Cell Mol Med. 2008;12(2):459–470
  40. Jander S, Schroeter M, Saleh A. Imaging inflammation in acute brain ischemia. Stroke. 2007;38(2 Suppl):642–645

PII: S0730-725X(09)00303-8

doi: 10.1016/j.mri.2009.12.011

Magnetic Resonance Imaging
Volume 28, Issue 4 , Pages 477-486 , May 2010

Article Tools

* Image Usage & Resolution